Enhanced 13C NMR by Thermal Mixing with Hyperpolarized 129XE
Abstract
A method of preparing a hydrogen-containing 13 C compound test sample exhibiting an enhanced 13 C nuclear magnetic resonance (NMR) signal when exposed to a 13 C NMR pulse sequence is disclosed. In the disclosed method, the hydrogen-containing 13 C compound is mixed with hyperpolarized 129 Xe in the gaseous state, and the mixture is subsequently frozen within a magnetic field. The magnetic field strength is then reduced sufficiently so that spin polarization is transferred from the hyperpolarized 129 Xe to the compound. The magnetic field strength is then increased, and the mixture is thawed to obtain the test sample.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of preparing a hydrogen-containing carbon-13 ( 13 C) compound test sample exhibiting an enhanced 13 C nuclear magnetic resonance (NMR) signal when exposed to a 13 C NMR pulse sequence comprising the steps of:
(a) mixing a compound comprising hydrogen and 13 C and hyperpolarized Xenon-129 ( 129 Xe); (b) freezing the mixture within a magnetic field; (c) reducing the magnetic field strength sufficiently so that spin polarization is transferred from the hyperpolarized 129 Xe to the compound; (d) increasing the magnetic field strength; and (e) thawing the mixture to obtain a test sample exhibiting enhanced 13 C polarization when undergoing NMR analysis.
2 . The method of claim 1 , wherein both the compound and hyperpolarized 129 Xe are mixed in the gas phase.
3 . The method of claim 2 , wherein the compound is in the liquid phase at room temperature and pressure.
4 . The method of claim 3 , wherein the compound is in the form of a vapor of the liquid phase.
5 . The method of claim 1 , wherein the compound has low solubility in liquid xenon.
6 . The method of claim 1 , wherein the 129 Xe is hyperpolarized by optical pumping.
7 . The method of claim 1 , wherein the compound is mixed with hyperpolarized 129 Xe on a chromatographic column.
8 . The method of claim 1 , wherein the mixture is frozen as a thin film.
9 . The method of claim 1 , wherein the mixture is thawed by applying a radio frequency pulse to the mixture.
10 . The method of claim 1 , wherein the magnetic field within which the mixture is frozen is a magnet's fringe field.
11 . The method of claim 1 , wherein the step of reducing the magnetic field strength sufficiently so that spin polarization is transferred is performed by increasing the field strength of a separate electromagnet that compensates the existing magnetic field, and the step of increasing the magnetic field strength is performed by decreasing the field strength of said electromagnet.
12 . The method of claim 1 , wherein the compound is a compound of biological relevance.
13 . The method of claim 12 , wherein the compound of biological relevance is chosen from the group consisting of acetic acid, acetate salts, pyruvate salts, and ethanol.
14 . The method of claim 13 , wherein the compound is 1- 13 C-AcH (acetic acid), Na-1- 13 C-acetate, or 2- 13 C-EtOH (ethanol).
15 . The method of claim 14 , wherein the compound is 1- 13 C-AcH.
16 . A method for mixing a test sample having one or more hydrogen-containing 13 C compound(s) and subsequently analyzing the test sample comprising the steps of:
(a) vaporizing a composition containing one or more compound(s) comprising hydrogen and 13 C and mixing the vapor with hyperpolarized 129 Xe; (b) freezing the resulting mixture within a magnetic field; (c) reducing the magnetic field strength sufficiently so that spin polarization is transferred from the hyperpolarized 129 Xe to the compound(s) within the frozen mixture; (d) increasing the magnetic field strength; (e) thawing the mixture to obtain a test sample; applying a 13 C nuclear magnetic resonance (NMR) pulse sequence to the test sample; and (g) detecting the 13 C active nuclei in the test sample by NMR spectroscopy, magnetic resonance imaging (MM), or both.
17 . The method of claim 16 , wherein the one or more compound(s) comprising hydrogen and 13 C are compounds of biological relevance and that have low solubility in liquid xenon.
18 . The method of claim 16 , wherein the step of thawing the mixture to obtain the test sample further comprises the step of exposing the mixture to other substances to obtain the test sample.
19 . A test composition comprising a hydrogen-containing carbon-13 ( 13 C) compound exhibiting an enhanced 13 C nuclear magnetic resonance (NMR) signal when exposed to a 13 C NMR pulse sequence, said test composition comprising the test sample resulting from practicing the method according to claim 1 .
20 . The test composition of claim 19 , wherein the hydrogen-containing 13 C compound is a compound of biological relevance that has low solubility in liquid xenon.Join the waitlist — get patent alerts
Track US2016274043A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.